Anti-Mineralocorticoid Receptor antibody (ab62532)

Overview

  • Product nameAnti-Mineralocorticoid Receptor antibody
    See all Mineralocorticoid Receptor primary antibodies
  • Description
    Rabbit polyclonal to Mineralocorticoid Receptor
  • Tested applicationsSuitable for: WB, IHC-Pmore details
  • Species reactivity
    Reacts with: Human
    Predicted to work with: Mouse, Rat, Rabbit, Horse, Chicken, Pig, Spider Monkey
  • Immunogen

    A region within synthetic peptide: KIRRKNCPAC RLQKCLQAGM NLGARKSKKL GKLKGIHEEQ PQQQQPPPPP, corresponding to internal sequence amino acids 649-698 of Human Mineralocorticoid Receptor

  • Positive control
    • A172 cell lysate. Human kidney tissue.

Properties

Associated products

Applications

Our Abpromise guarantee covers the use of ab62532 in the following tested applications.

The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.

Application Abreviews Notes
WB Use a concentration of 1.25 µg/ml. Detects a band of approximately 90 kDa (predicted molecular weight: 107 kDa).Can be blocked with Human Mineralocorticoid Receptor peptide (ab87358). Good results were obtained when blocked with 5% non-fat dry milk in 0.05% PBS-T.
IHC-P Use a concentration of 4 - 8 µg/ml.

Target

  • FunctionReceptor for both mineralocorticoids (MC) such as aldosterone and glucocorticoids (GC) such as corticosterone or cortisol. Binds to mineralocorticoid response elements (MRE) and transactivates target genes. The effect of MC is to increase ion and water transport and thus raise extracellular fluid volume and blood pressure and lower potassium levels.
  • Tissue specificityUbiquitous. Highly expressed in distal tubules, convoluted tubules and cortical collecting duct in kidney, and in sweat glands. Detected at lower levels in cardiomyocytes, in epidermis and in colon enterocytes.
  • Involvement in diseaseDefects in NR3C2 are a cause of autosomal dominant pseudohypoaldosteronism type I (AD-PHA1) [MIM:177735]. PHA1 is characterized by urinary salt wasting, resulting from target organ unresponsiveness to mineralocorticoids. There are 2 forms of PHA1: the autosomal dominant form that is mild, and the recessive form which is more severe and due to defects in any of the epithelial sodium channel subunits. In AD-PHA1 the target organ defect is confined to kidney. Clinical expression can vary from asymptomatic to moderate. It may be severe at birth, but symptoms remit with age. Familial and sporadic cases have been reported.
    Defects in NR3C2 are a cause of early-onset hypertension with severe exacerbation in pregnancy (EOHSEP) [MIM:605115]. Inheritance is autosomal dominant. The disease is characterized by the onset of severe hypertension before the age of 20, and by suppression of aldosterone secretion.
  • Sequence similaritiesBelongs to the nuclear hormone receptor family. NR3 subfamily.
    Contains 1 nuclear receptor DNA-binding domain.
  • DomainComposed of three domains: a modulating N-terminal domain, a DNA-binding domain and a C-terminal ligand-binding domain.
  • Post-translational
    modifications
    Phosphorylated.
  • Cellular localizationCytoplasm. Nucleus. Endoplasmic reticulum membrane. Cytoplasmic and nuclear in the absence of ligand; nuclear after ligand-binding. When bound to HSD11B2, it is found associated with the endoplasmic reticulum membrane.
  • Information by UniProt
  • Database links
  • Alternative names
    • Aldosterone receptor antibody
    • MCR antibody
    • MCR_HUMAN antibody
    • MGC133092 antibody
    • Mineralocorticoid receptor antibody
    • MLR antibody
    • MR antibody
    • NR3 C2 antibody
    • NR3C2 antibody
    • NR3C2 protein antibody
    • Nuclear receptor subfamily 3 group C member 2 antibody
    see all

Anti-Mineralocorticoid Receptor antibody images

  • Anti-Mineralocorticoid Receptor antibody (ab62532) at 1.25 µg/ml + A172 cell lysate at 10 µg

    Secondary
    HRP conjugated anti-Rabbit IgG at 1/50000 dilution

    Predicted band size : 107 kDa
    Observed band size : 90 kDa (why is the actual band size different from the predicted?)
    Gel concentration: 8%
  • Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) analysis of human kidney tissue labelling Mineralocorticoid Receptor with ab62532 at 4-8µg/ml. Arrows indicate positively labelled epithelial cells of the renal tubule. Magnification: 400X.

References for Anti-Mineralocorticoid Receptor antibody (ab62532)

ab62532 has not yet been referenced specifically in any publications.

Product Wall

There are currently no Abreviews or Questions for ab62532.
Please use the links above to contact us or submit feedback about this product.

Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"